Montai Therapeutics
montai.com
Actively hiring
Medical AI
Drug Discovery
Artificial Intelligence
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Backers
1
Flagship Pioneering
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Backed byfrom the funds' portfolios and accelerator catalogs
Flagship Pioneering Similar startupsby what they do, their industry and backers
Defining a new era in drug discovery where chemistry rewrites the rules of biology to engage any protein target.
Light Horse is a small molecule drug discovery company that is leading the way in a.
Streamline discovery with our integrated drug discovery platform, blending AI, physics-based tools, and wet lab for unparalleled…
AI-powered in silico toxicology platform for drug discovery. Predict mutagenicity, hERG, DILI, ADME and 55+ models from SMILES…
Gandeeva Therapeutics is a precision medicine company leveraging cryo-EM and machine learning for drug discovery.
We accelerate the discovery of new medicines by combining the power of robotics, data science, and deep biological expertise to generate…
News
Montai Therapeutics Presents Preclinical Data on NRF2 Agonist in Ulcerative Colitis at ACAAI Annual Meeting
CAMBRIDGE, Mass., November 06, 2025--Montai will present data for the first time on its novel oral NRF2 agonist molecule, MTAI-1025, for ulcerative colitis (UC) during ACAAI in Orlando.
Read more
Report
Report
Report
Montai Therapeutics Appoints Allison Bogosian, JD, as Chief People and Administrative Officer
Read more
Report
Flagship Pioneering Announces Two New Agreements With Ampersand Biomedicines And Montai Therapeutics Under Its Strategic Partnership With Pfizer
Flagship Pioneering Announces Two New Agreements With Ampersand Biomedicines And Montai Therapeutics Under Its Strategic Partnership With Pfizer. Ampersand
Read more
Report
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer
These agreements represent the most recent collaborations initiated under Flagship's strategic partnership with Pfizer Inc. announced in July 2023 and will leverage Pfizer's deep expertise in early discovery and development for new targeted therapies. "Th
Read more
Report
Spotlight: Montai Builds a Multimodal AI Platform for Drug Discovery Using NVIDIA NIM Microservices
Drug discovery aims to develop new therapeutic agents that effectively target diseases while minimizing side effects for patients. Using multimodal data-such as…
Read more
Report
Report
Show more news